Impact of (68)Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study

The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established. However, whether and how PSMA PET/CT affects the management of patients undergoing scans for other clinical indications remains unknow...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Nucl Med
Päätekijät: Sonni, Ida, Eiber, Matthias, Fendler, Wolfgang P., Alano, Rejah M., Vangala, Sitaram S., Kishan, Amar U., Nickols, Nicholas, Rettig, Matthew B., Reiter, Robert E., Czernin, Johannes, Calais, Jeremie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Society of Nuclear Medicine 2020
Aiheet:
Theranostics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7413232/
https://ncbi.nlm.nih.gov/pubmed/31924715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.237602
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia